ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Caelyx, Konzentrat zur Herstellung einer Infusionslösung - 20 mg / 10 ml
54273010 Baxter AG
Caelyx, Konzentrat zur Herstellung einer Infusionslösung24.12.1997
  24.12.1997
Doxorubicin (L01DB01)20.02.2007
WHO-DDD 
07.16.10.20 mg / 10 ml
07.16.10.1 Durchstechflasche zu
A  
Yes 
IP 
232.38Yes
    
10 %269.15
  
7680542730103Synthetika
2049855 
Composition
doxorubicini hydrochloridum 2 mg, N-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum, phosphatidylcholinum ex soja hydrogenatum, cholesterolum, ammonii sulfas, saccharum, histidinum, acidum hydrochloridum aut natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 0.054 mg.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Doxorubicin Hydrochloride2 mg/ml
BAG: Active AgentDose
Doxorubicini Hydrochloridum, peg Liposomal20 mg
 
Inactive agents
Acidum Hydrochloridum aut Natrii Hydroxidum
Ammonii Sulfas
Cholesterol
Histidine
N-(carbonyl-Methoxypolyethylenglycoli 2000)-1,2-distearoyl-Sn-Glycero-3-Phosphoethanolaminum Natricum
Phosphatidylcholinum ex soja Hydrogenatum
Saccharum
 
Source
Data was imported : 07.07.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home